Sian Jones
Infectious Disease · New York, NYNPI 1083751739
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $405,900 of the $405,900 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer. Reporting peaked in 2024 at $164,550 and has fallen 62.9% since, to $61,050 in 2025. Among infectious disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $2387.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$406K
What the payments were for
- Consulting fees$405,900100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 170 | $405,900 |
How this compares
$405,900 in reported general payments places this provider in the 95th percentile of 799 infectious disease providers in New York.
Other infectious disease in New York
- Antonio UrbinaNew York$373K
- David BekhorNew York$358K
- Genovefa PapanicolaouNew York$209K
- Michelle CespedesNew York$125K
- Donald KaminskyNew York$120K
- Judith AbergNew York$104K
- Thomas WalshNew York$98K
- Stuart HaberNew York$73K
- Michael GaisaNew York$47K
- Joseph FeczkoNew York$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.